Form 8-K - Current report:
SEC Accession No. 0001193125-25-142725
Filing Date
2025-06-18
Accepted
2025-06-18 16:16:46
Documents
12
Period of Report
2025-06-13
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d945146d8k.htm   iXBRL 8-K 28993
  Complete submission text file 0001193125-25-142725.txt   147731

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA prta-20250613.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE prta-20250613_lab.xml EX-101.LAB 18690
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prta-20250613_pre.xml EX-101.PRE 11689
15 EXTRACTED XBRL INSTANCE DOCUMENT d945146d8k_htm.xml XML 3833
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 251057176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)